India Pharma: Reduce Import Reliance, Says Commerce Secretary

Commerce Secretary Rajesh Agrawal has called on India’s pharmaceutical sector to enhance its domestic production capabilities and diminish its reliance on imported raw materials.

During a recent address, Agrawal emphasized the importance of diversifying export markets to effectively navigate the complexities of the global economic landscape. He stressed that India should aspire to become a leading global hub for producing high-quality and cost-effective medicines.

Agrawal highlighted that a key focus should be placed on fostering innovation within the pharmaceutical industry and transitioning towards a value-driven operational model. This approach, he noted, is crucial for sustaining growth and competitiveness in the international market.